From August 18th 2026, GtoPdb will require users to register to use the website. Please see our blog post for more information.
|
Synonyms: glutathione disulfide | Navstel®
oxiglutatione is an approved drug (FDA (2008)-see Comment)
Compound class:
Synthetic organic
Comment: The approved drug in this case is Navstel®. Oxiglutatione is listed as the active ingredient. Inhibits glutathione reductase. Note that the chemical structure given by DrugBank has opposite stereochemistry to the INN record and the ChEMBL ligand mapped here.
|
|
|||||||||||||||||||||||||||||||||||
| Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
| Targets where the ligand is described in the comment field | |
| Target | Comment |
| AcetylCoA transporter | Exports oxidized glutathione (GSSG; oxiglutatione) to maintain endoplasmic reticulum redox homeostasis [1]. |